Stella Pharma Corporation (4888.T)
JPY 555.0
(0.18%)
JPY 555.0
(0.18%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 269.49 Million | 229.06 Million | 100.09 Million | 205.96 Million | - |
| Cost of Revenue | 52.19 Million | 22.12 Million | 15.23 Million | 24.19 Million | 29.04 Million |
| Gross Profit | 217.29 Million | 206.94 Million | 84.85 Million | 181.77 Million | -29.04 Million |
| Operating Expenses | 963.98 Million | 1.01 Billion | 826.76 Million | 862.34 Million | 960 Million |
| Selling, General and Administrative Expenses | 571 Million | 625 Million | 555 Million | 539 Million | 951 Million |
| Research and Development Expenses | 393.55 Million | 374 Million | 255 Million | 307 Million | 441.36 Million |
| Other Expenses | - | 39.11 Million | 17.85 Million | 27.41 Million | - |
| Cost and Expenses | 1.02 Billion | 1.03 Billion | 841.99 Million | 886.53 Million | 960 Million |
| Operating Income | -760.3 Million | -806.77 Million | -741.9 Million | -680.56 Million | -951 Million |
| Interest Expense | 2.08 Million | 2.58 Million | 3.1 Million | 3.24 Million | - |
| Income Tax Expense | 2.77 Million | 2.85 Million | 3.63 Million | 2.85 Million | 2 Million |
| Earnings before Tax | -760.97 Million | -775.97 Million | -764.08 Million | -656.39 Million | -960 Million |
| Net Income | -763.74 Million | -778.82 Million | -767.71 Million | -659.24 Million | -962 Million |
| Earnings Per Share Basic | -24.66 | -26.97 | -27.34 | -32.90 | -48.02 |
| Earnings Per Share Diluted | -24.66 | -26.97 | -27.34 | -32.90 | -34.95 |
| Weighted Average Shares Outstanding | 30.97 Million | 28.87 Million | 28.08 Million | 20.03 Million | 20.03 Million |
| Weighted Average Shares Outstanding (Diluted) | 30.97 Million | 28.87 Million | 28.08 Million | 20.03 Million | 27.52 Million |
| Gross Margin | 0.81 | 0.90 | 0.85 | 0.88 | - |
| EBIT Margin | -2.69 | -3.22 | -7.26 | -3.02 | - |
| Profit Margin | -2.83 | -3.40 | -7.67 | -3.20 | - |
| EBITDA | -723.85 Million | -738.34 Million | -726.85 Million | -621.69 Million | -7.82 Million |
| Earnings Before Tax Margin | -2.82 | -3.52 | -7.41 | -3.30 | - |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 61.59 Million | 69.29 Million | 269.49 Million | 46.19 Million | 92.39 Million | 61.59 Million |
| Cost of Revenue | 18.56 Million | 14.68 Million | 52.19 Million | 6.59 Million | 23.63 Million | 7.28 Million |
| Gross Profit | 43.03 Million | 54.61 Million | 217.29 Million | 39.6 Million | 68.76 Million | 54.3 Million |
| Operating Expenses | 209.93 Million | 347.94 Million | 977.59 Million | 205.34 Million | 206.93 Million | 217.36 Million |
| Selling, General and Administrative Expenses | 209.93 Million | 58 Million | - | 205 Million | 207 Million | 217 Million |
| Research and Development Expenses | - | 393 Million | - | 63.52 Million | 75.2 Million | 69.79 Million |
| Other Expenses | - | 106 Thousand | 3.18 Million | 3.02 Million | 50 Thousand | 2000.00 |
| Cost and Expenses | 228.49 Million | 362.62 Million | 1.02 Billion | 211.93 Million | 230.56 Million | 224.65 Million |
| Operating Income | -166.9 Million | -293.33 Million | -760.3 Million | -165.73 Million | -138.17 Million | -163.06 Million |
| Interest Expense | 777 Thousand | 506 Thousand | 2.08 Million | 517 Thousand | 506 Thousand | 555 Thousand |
| Income Tax Expense | 712 Thousand | 634 Thousand | 2.77 Million | 713 Thousand | 713 Thousand | 712 Thousand |
| Earnings before Tax | -161.04 Million | -293.55 Million | -760.97 Million | -162.99 Million | -139.44 Million | -164.98 Million |
| Net Income | -161.76 Million | -294.18 Million | -763.74 Million | -163.7 Million | -140.15 Million | -165.69 Million |
| Earnings Per Share Basic | -5.12 | -9.42 | - | -5.24 | -4.52 | -5.45 |
| Earnings Per Share Diluted | -5.12 | -9.42 | - | -5.24 | -4.52 | -5.45 |
| Weighted Average Shares Outstanding | 31.61 Million | 31.22 Million | 30.97 Million | 31.22 Million | 31.03 Million | 30.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 31.61 Million | 31.22 Million | 30.97 Million | 31.22 Million | 31.03 Million | 30.41 Million |
| Gross Margin | 0.70 | 0.79 | 0.81 | 0.86 | 0.74 | 0.88 |
| EBIT Margin | -2.54 | -4.23 | - | -3.52 | -1.50 | -2.66 |
| Profit Margin | -2.63 | -4.25 | -2.83 | -3.54 | -1.52 | -2.69 |
| EBITDA | -156.32 Million | -293.04 Million | - | -162.45 Million | -138.93 Million | -163.68 Million |
| Earnings Before Tax Margin | -2.71 | -4.23 | -2.82 | -3.59 | -1.50 | -2.65 |
CBSH
3695
603318
TKC
0Z62
GOEV